Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
|
2. Transaction Date (MM/DD/YY)
|
2A. Deemed Execution Date, if any (MM/DD/YY)
|
3. Transaction Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
|
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock |
03/29/2021 |
|
S(
1
) |
|
284,300 (
2
) |
D |
$
122.5349 (
2
) |
12,585,162 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/29/2021 |
|
S(
1
) |
|
639,681 (
4
) |
D |
$
123.4965 (
4
) |
11,945,481 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/29/2021 |
|
S(
1
) |
|
251,545 (
5
) |
D |
$
124.4188 (
5
) |
11,693,936 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/29/2021 |
|
S(
1
) |
|
116,383 (
6
) |
D |
$
125.3553 (
6
) |
11,577,553 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/29/2021 |
|
S(
1
) |
|
82,557 (
7
) |
D |
$
126.3966 (
7
) |
11,494,996 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/29/2021 |
|
S(
1
) |
|
46,872 (
8
) |
D |
$
127.4703 (
8
) |
11,448,124 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/29/2021 |
|
S(
1
) |
|
123,374 (
9
) |
D |
$
128.7429 (
9
) |
11,324,750 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/29/2021 |
|
S(
1
) |
|
83,242 (
10
) |
D |
$
129.5425 (
10
) |
11,241,508 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/29/2021 |
|
S(
1
) |
|
6,610 (
11
) |
D |
$
130.5588 (
11
) |
11,234,898 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/29/2021 |
|
S(
1
) |
|
558 (
12
) |
D |
$
131.3 |
11,234,340 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/30/2021 |
|
S(
1
) |
|
883,277 (
13
) |
D |
$
118.0443 (
13
) |
10,351,063 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/30/2021 |
|
S(
1
) |
|
611,922 (
14
) |
D |
$
118.9016 (
14
) |
9,739,141 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/30/2021 |
|
S(
1
) |
|
344,542 (
15
) |
D |
$
119.8056 (
15
) |
9,394,599 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/30/2021 |
|
S(
1
) |
|
225,732 (
16
) |
D |
$
120.7595 (
16
) |
9,168,867 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/30/2021 |
|
S(
1
) |
|
14,379 (
17
) |
D |
$
121.7079 (
17
) |
9,154,488 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/30/2021 |
|
S(
1
) |
|
31,943 (
18
) |
D |
$
123.0798 (
18
) |
9,122,545 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/30/2021 |
|
S(
1
) |
|
1,000 (
19
) |
D |
$
123.44 |
9,121,545 |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
03/31/2021 |
|
S(
1
) |
|
4,888 (
20
) |
D |
$
121.074 (
20
) |
9,116,657 (
21
) |
I |
By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. (
3
) |
Common Stock |
|
|
|
|
|
|
|
11,464,359 (
22
) |
I |
By Flagship VentureLabs IV LLC and Flagship Pioneering, Inc. (
22
) |
Common Stock |
|
|
|
|
|
|
|
2,101,703 |
D |
|
|